Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 173

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Sublingual immunotherapy with Dermatophagoides monomeric allergoid down‐regulates allergen‐specific immunoglobulin E and increases both interferon‐γ‐ and interleukin‐10‐production

Cosmi, L., Santarlasci, V., Angeli, R., Liotta, F., Maggi, L., Frosali, F., Rossi, O., Falagiani, P., Riva, G., Romagnani, S., Annunziato, F., Maggi, E. · 2006 · Clinical & Experimental Allergy

Abstract

Summary: Background The clinical efficacy and safety of sublingual immunotherapy (SLIT) for aeroallergens has been demonstrated in several trials, whereas the immunological changes induced by this treatment, which may account for the clinical improvement, are still unclear. Objective To investigate the effects of a successful SLIT on the in vitro allergen‐driven T cell response and cytokine secretion as well as on the serum levels of chemokines and of IgE, IgG1 and IgG4 antibodies (Abs). Materials and methods Twenty‐five Dermatophagoides pteronyssinus (Dp)‐sensitive patients with perennial rhinitic and/or rhinitic and asthmatic symptoms were randomized into two groups (13 untreated (UT) and 12 SLIT‐treated) for a 1 year and half study. The proliferative response of peripheral blood mononuclear cell (PBMC) to purified Der p1 allergen, their cytokines (IFN‐γ, IL‐4, IL‐10 and TGF‐β) production and serum levels of chemokines associated with T helper type 1 (Th1) (CXCL10) or T helper type 2 (Th2) (CCL22) responses and of Dp‐specific IgE, IgG1 and IgG4 Abs were evaluated before and after 6 months of treatment. Results SLIT induced a significant reduction of symptom medication scores after 6, 12 and 18 months of treatment in comparison with UT patients. SLIT‐treated patients showed a significant decrease in serum levels of DP‐specific IgE Abs, whereas total IgE, and specific IgG1 and IgG4 Abs remained unchanged. The proliferative response of allergen‐specific T cells to Der p1 in vitro after 6 months of treatment was reduced, while no effect was observed on T cell proliferation to recall antigen (streptokinase). Moreover, Der p1‐driven IFN‐γ and IL‐10 were significantly increased in culture supernatants of PBMC from 6 month‐treated patients in comparison with those detected at the beginning of therapy. Conclusions These data suggest that the allergen‐driven enhancement of IL‐10‐ and IFN‐γ‐producing T cells precedes and associates with SLIT‐induced down‐regulation of specific IgE, thus providing a rationale to explain the clinical benefit of SLIT in allergic patients.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1365-2222.2006.02429.x

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Cited by

See all 173

Metadata

Authors
Cosmi, L., Santarlasci, V., Angeli, R., Liotta, F., Maggi, L., Frosali, F., Rossi, O., Falagiani, P., Riva, G., Romagnani, S., Annunziato, F., & Maggi, E.
Venue
Clinical & Experimental Allergy
Publisher
Wiley
Published
2006-01-27
Volume
36
Issue
3
Pages
261-272
ISSN
  • 0954-7894 (ISSN-L)
  • 1365-2222
OpenAlex
W2117076737
Cited by
173
References
2
FWCI
11.53
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Sublingual immunotherapy with Dermatophagoides monomeric allergoid down‐regulates allergen‐specific immunoglobulin E and increases both interferon‐γ‐ and interleukin‐10‐production. https://app.cochat.ai/papers/10.1111/j.1365-2222.2006.02429.x
The paper
Cosmi, L., Santarlasci, V., Angeli, R., Liotta, F., Maggi, L., Frosali, F., Rossi, O., Falagiani, P., Riva, G., Romagnani, S., Annunziato, F., & Maggi, E. (2006). Sublingual immunotherapy with Dermatophagoides monomeric allergoid down‐regulates allergen‐specific immunoglobulin E and increases both interferon‐γ‐ and interleukin‐10‐production. Clinical & Experimental Allergy. https://doi.org/10.1111/j.1365-2222.2006.02429.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.